« Return to News | CROs/Service Providers

Medpace Buys Medical Device CRO Symbios

Wednesday, April 7, 2010 01:55 PM

Cincinnati-based contract research organization (CRO) Medpace acquired medical device CRO Symbios for an undisclosed amount. Symbios was advised by Fairmount Partners in this transaction.

Symbios supports medical device research with experience in pre-market, post-approval and post-market clinical trials. The company will continue to operate out of its Minneapolis, Minn., headquarters. Symbios’ founder and CEO Ryan Wilson and his management team will continue to lead Medpace’s medical device business, now named Symbios Clinical, as a member of the Medpace group of companies.

“The ability of Medpace to tap into this innovative company for benefit of our existing and new Sponsors will be valuable as yet another service area for Medpace, and allow Symbios to benefit from our established global infrastructure,” said Medpace president and CEO August Troendle in a statement.

Medpace offers services in phase I to IV clinical trial management, bio-imaging, central laboratory and clinical pharmacology. The CRO has European headquarters in The Netherlands, Asian headquarters in Singapore and regional offices throughout Europe, Asia, Australia, South Africa and the Americas.

Earlier this year, the company acquired Germany-based CRO Medical Consulting Dr. Schlichtiger. At the time, Medpace had 1,000 employees worldwide but announced plans to almost double its headcount by 2014.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.